BioSpace News Archive

Gossamer Bio, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2022 and provided a business update.

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announced financial results for the fourth quarter and fiscal year ended December 31, 2022 and provided a corporate update.

Tiziana Life Sciences Ltd. today announces that it has been notified that Gabriele Cerrone, its Chairman and Acting Chief Executive Officer, purchased 25,000 common shares at $0.58 per share, bringing his total holding to 38,640,737 common shares.

Relmada Therapeutics, Inc. (Nasdaq: RLMD) today announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2022 after the market close on Thursday, March 23, 2023.

SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services, today announced its operating and financial results for the fourth quarter and year ended December 31, 2022.

RVAC Medicines (US), Inc. today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) focused on the discovery and development of mRNA vaccines that can modulate the body’s normal immune response as possible treatments for certain autoimmune diseases and allergic conditions.

Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial with Rosuzet have been published in ‘The Lancet’ and the ‘European Heart Journal’.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held virtually and in Dallas, Tex., March 19-22.

Biostarks, a digital health company, is pleased to announce the launch of its innovative at-home longevity test kits.

Bayer and Kimitec announced a new strategic partnership focused on accelerating the development and commercialization of biological crop protection solutions and biostimulants.